Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
Maddalena Napolitano, Francesca di Vico, Angelo Ruggiero, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 25

Showing 25 citing articles:

Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases
Roberto Berni Canani, Marco Caminati, Laura R. Carucci, et al.
Allergy (2024) Vol. 79, Iss. 6, pp. 1485-1500
Open Access | Times Cited: 17
Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?
Francesco Giombi, Gian Marco Pace, Francesca Pirola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 730-730
Open Access | Times Cited: 9
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children
Eric L. Simpson, Adelaide A. Hebert, John Browning, et al.
Dermatology and Therapy (2025)
Open Access
The evolving therapeutic landscape in atopic dermatitis
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment
Joe Gorelick, Andrea Nguyen, Shannon Schneider, et al.
American Journal of Clinical Dermatology (2025)
Open Access
Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitis
Meritxell Oliva, Mrinal K. Sarkar, Michael March, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Population Pharmacokinetic-Pharmacodynamic (popPK/PD) Relationship of Orismilast, A Potent and Selective PDE4B/D Inhibitor, in Atopic Dermatitis
Richard B. Warren, Anne Weiss, Jakob Felding, et al.
Dermatology and Therapy (2025)
Open Access
RELATIONSHIP BETWEEN PATIENTS WITH ATOPIC DERMATITIS AND THE INCIDENCE OF STROKE: A SYSTEMATIC REVIEW WITH META-ANALYSIS
Luiz Carlos Figueiredo Filho, Ricardo Ormanes Massoud, Rafael Augusto Silva Cabeça, et al.
Clinical Neurology and Neurosurgery (2025), pp. 108888-108888
Closed Access
Effects of Psychological Stress on Spontaneous Itch and Mechanical Alloknesis of Atopic Dermatitis
Qiao-Feng Zhao, Mitsutoshi Tominaga, Sumika Toyama, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv18685-adv18685
Open Access | Times Cited: 3
MRGPRX2 antagonist GE1111 attenuated DNFB-induced atopic dermatitis in mice by reducing inflammatory cytokines and restoring skin integrity
Trevor K. Wong, Ye Gi Choi, Philip H. Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials
Monika Marko, Rafał Pawliczak
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 1, pp. 121-134
Closed Access | Times Cited: 7
LncRNA microarray profiling identifies novel circulating lncRNAs in hidradenitis suppurativa
Bruna De Felice, Pasquale De Luca, Concetta Montanino, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review
Emeka Ogiji, Nourah Aboheimed, Kehinde Ross, et al.
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 4, pp. 218-227
Open Access | Times Cited: 2
Cheungsam Seed Husk Extract Reduces Skin Inflammation through Regulation of Inflammatory Mediator in TNF-α/IFN-γ-Induced HaCaT Cells
Jiye Han, Yun Jung Lee, Do-Won Lim, et al.
Plants (2024) Vol. 13, Iss. 12, pp. 1704-1704
Open Access | Times Cited: 2
Polysaccharide-based hydrogels for atopic dermatitis management: A review
Harinash Rao, Joash Ban Lee Tan
Carbohydrate Polymers (2024) Vol. 349, pp. 122966-122966
Open Access | Times Cited: 2
Multi-Ancestry Genome-Wide Association Meta-Analysis Identifies Novel Loci in Atopic Dermatitis
Meritxell Oliva, Mrinal K. Sarkar, Michael March, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
Kyu-Hye Chun, Ye-Chan Park, Nahee Hwang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
Elena Pezzolo, Andrea Sechi, Jacopo Tartaglia, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 3, pp. 255-266
Closed Access | Times Cited: 2
Avaliação da resposta imune celular em indivíduos alérgicos a mandioca com o alérgeno recombinante Man e 5
Safiri de Paiva Alves
(2024)
Open Access
Study the impact of the Interlukines and Vit.E in patients with Atopic Eczema in Anbar Governorate
Haneen Abdullah, Wajeeh Mohammed, Abdullah Al Hasan
Journal of university of Anbar for pure science (2024) Vol. 18, Iss. 1, pp. 180-189
Open Access
An Encompassing Review on Therapeutic Targets, Therapies and Nanostructure Based Formulations for Atopic Dermatitis
R Monisha, Jawahar Natarajan, Jigyasa Singh, et al.
International Journal of Pharmaceutical Sciences and Nanotechnology (2024) Vol. 17, Iss. 4, pp. 7519-7551
Closed Access
Lebrikizumab▼: Short and Long-Term Disease Control in Moderate-to-Severe AD Through Selective IL-13 Inhibition
EMJ EMJ
European Medical Journal (2024), pp. 46-47
Open Access
Regulatory Role of IL6 in Immune-Related Adverse Events during Checkpoint Inhibitor Treatment in Melanoma
Krishna P. Singh, Anuj Singh, Olaf Wolkenhauer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10600-10600
Open Access
Characterization of Inflammatory Mediators and Metabolome in Interstitial Fluid Collected with Dermal Open Flow Microperfusion before and at the End of Dupilumab Treatment in Atopic Dermatitis
Fernanda Monedeiro, Barbara Ehall, Katrin Tiffner, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 3496-3514
Open Access
Cytokine Profiling of Erythroderma Biopsies Reveals Types 2 and 17 Immune Activation Status
Tatsiana Pukhalskaya, Mitchell Finkelstein, Dacia A. Miyake‐Caballero, et al.
Journal of Cutaneous Pathology (2024)
Closed Access
Page 1

Scroll to top